{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:47Z","timestamp":1788871667640,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Portuguese Foundation for Science and Technology","award":["SFRH\/BPD\/14883\/2003"],"award-info":[{"award-number":["SFRH\/BPD\/14883\/2003"]}]},{"name":"Portuguese Foundation for Science and Technology","award":["PEst-C\/SAU\/UI0709\/2011"],"award-info":[{"award-number":["PEst-C\/SAU\/UI0709\/2011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bbadis.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T05:01:30Z","timestamp":1394859690000},"page":"927-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways"],"prefix":"10.1016","volume":"1842","author":[{"given":"Carla Pais","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.03.003_bb0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archneur.64.8.1083","article-title":"Treatment options in the modern management of Parkinson disease","volume":"64","author":"Schapira","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00702-013-0981-5","article-title":"Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?","volume":"120","author":"Chaudhuri","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0020","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.0b013e3181990438","article-title":"Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease","volume":"72","author":"Schapira","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.maturitas.2013.05.019","article-title":"Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems","volume":"76","author":"Garbayo","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrn1477","article-title":"Adult neuron survival strategies \u2014 slamming on the brakes","volume":"5","author":"Benn","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-0173(00)00030-8","article-title":"Neurotrophic factors in Alzheimer's and Parkinson's disease brain","volume":"33","author":"Siegel","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn1886","article-title":"Ageing and neuronal vulnerability","volume":"7","author":"Mattson","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0079-6123(09)17514-3","article-title":"Trophic factors therapy in Parkinson's disease","volume":"175","author":"Ramaswamy","year":"2009","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(94)01366-P","article-title":"GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo","volume":"672","author":"Kearns","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0060","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1073\/pnas.92.19.8935","article-title":"Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion","volume":"92","author":"Sauer","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0065","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awf234","article-title":"Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys","volume":"125","author":"Grondin","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0070","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1523\/JNEUROSCI.23-05-01974.2003","article-title":"Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys","volume":"23","author":"Grondin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cne.10689","article-title":"Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects","volume":"461","author":"Ai","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jgm.1361","article-title":"Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles","volume":"11","author":"Huang","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2008.12.010","article-title":"Effective GDNF brain delivery using microspheres \u2014 a promising strategy for Parkinson's disease","volume":"135","author":"Garbayo","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0090","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/mds.23793","article-title":"Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease","volume":"26","author":"Garbayo","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0705-703","article-title":"Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain","volume":"11","author":"Love","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20374","article-title":"Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study","volume":"57","author":"Patel","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"issue":"Suppl. 3","key":"10.1016\/j.bbadis.2014.03.003_bb0115","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/S1353-8020(09)70810-7","article-title":"Parkinson's disease and growth factors \u2014 are they the answer?","volume":"15","author":"Barker","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0120","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1097\/00001756-200009280-00048","article-title":"Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion","volume":"11","author":"Zhou","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(01)02866-9","article-title":"GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons","volume":"916","author":"Nakajima","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(00)03217-0","article-title":"Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion","volume":"891","author":"Yurek","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neures.2007.07.007","article-title":"Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions","volume":"59","author":"Katoh-Semba","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0140","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1096\/fj.07-095398","article-title":"PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease","volume":"22","author":"Visanji","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jnr.20258","article-title":"Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis","volume":"78","author":"Nitta","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2013.06.011","article-title":"Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats","volume":"714","author":"Han","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0155","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2826.2012.02348.x","article-title":"GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones","volume":"24","author":"Campos","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0160","series-title":"Interactions Between Neurons and Glia in Aging and Disease","first-page":"173","article-title":"GDNF: a key player in neuron-glia crosstalk and survival of nigrostriatal dopaminergic neurons","author":"Duarte","year":"2007"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2006.04.008","article-title":"Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk","volume":"23","author":"Saavedra","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2006.08.019","article-title":"Interleukin-1beta mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures","volume":"25","author":"Saavedra","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0180","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2826.2007.01575.x","article-title":"Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system","volume":"19","author":"Karakaya","year":"2007","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1097-4547(19960215)43:4<490::AID-JNR10>3.0.CO;2-6","article-title":"Characterization of l-DOPA transport in cultured rat and mouse astrocytes","volume":"43","author":"Tsai","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0190","doi-asserted-by":"crossref","first-page":"C333","DOI":"10.1152\/ajpcell.2001.280.2.C333","article-title":"Regulatory pathways and uptake of l-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells","volume":"280","author":"Sampaio-Maia","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.1992.tb08363.x","article-title":"Gene expression of aromatic l-amino acid decarboxylase in cultured rat glial cells","volume":"59","author":"Li","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00008-2","article-title":"Autoradiographic studies using l-[(14)C]DOPA and l-DOPA reveal regional Na(+)-dependent uptake of the neurotransmitter candidate l-DOPA in the CNS","volume":"104","author":"Sugaya","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0197-0186(02)00075-X","article-title":"Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity","volume":"42","author":"Blessing","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuropharm.2009.11.003","article-title":"The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression","volume":"58","author":"Hung","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pneurobio.2008.09.006","article-title":"Driving GDNF expression: the green and the red traffic lights","volume":"86","author":"Saavedra","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0220","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1097\/00001756-199710200-00023","article-title":"Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli","volume":"8","author":"Appel","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/glia.10010","article-title":"Activation of astrocyte intracellular signaling pathways by interleukin-1 in rat primary striatal cultures","volume":"37","author":"Dunn","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/exnr.1997.6659","article-title":"Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice","volume":"148","author":"Ho","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","article-title":"Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer","volume":"17","author":"Katso","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0240","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.03.003_bb0245","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.yexcr.2007.05.002","article-title":"Common and distinct factors regulate expression of mRNA for ETV5 and GDNF, Sertoli cell proteins essential for spermatogonial stem cell maintenance","volume":"313","author":"Simon","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4196\/kjpp.2008.12.2.37","article-title":"Melatonin induces Akt phosphorylation through melatonin receptor- and PI3K-dependent pathways in primary astrocytes","volume":"12","author":"Kong","year":"2008","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/msb.2009.4","article-title":"PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk","volume":"5","author":"Wang","year":"2009","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0260","doi-asserted-by":"crossref","first-page":"27665","DOI":"10.1074\/jbc.272.44.27665","article-title":"Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength","volume":"272","author":"Duckworth","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0960-9822(00)00475-9","article-title":"Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338","volume":"10","author":"Chaudhary","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0270","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1128\/MCB.17.8.4406","article-title":"Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1\/mitogen-activated protein kinase pathway activation","volume":"17","author":"King","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2014.03.003_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj3030021","volume":"303","author":"Cross","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0280","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/MCB.15.6.3049","article-title":"Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway","volume":"15","author":"Karnitz","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0285","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0952-7915(96)80131-2","article-title":"Mitogen-activated protein kinase cascades and regulation of gene expression","volume":"8","author":"Su","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbadis.2014.03.003_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2760(98)00139-8","article-title":"Structure and function of phosphoinositide 3-kinases","volume":"1436","author":"Wymann","year":"1998","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:42:41Z","timestamp":1565257361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0925443914000635"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.03.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}